Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis

Handbook of Experimental Pharmacology

Volumn 176, Issue PART2, 2006, Pages 157-212

  Fischer, C ^a   Schneider, M ^a   Carmeliet, P ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Angiogenesis; Angiogenic disorders; Anti angiogenic therapy; Arteriogenesis; Endothelial progenitors; Guided navigation; Haematopoietic progenitors; Vasculogenesis; Vessel growth

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN;

ANGIOGENESIS; ANIMAL; ARTERY; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOTION; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; HEART MUSCLE ISCHEMIA; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; VASCULARIZATION; VEIN;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; ARTERIES; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; MYOCARDIAL ISCHEMIA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; VEINS;

EID: 34648849889     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-36028-x_6     Document Type: Article

References (370)

1. Abd El Aal DE, Mohamed SA, Amine AF, Meki AR (2005) Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Eur J Obstet Gynecol Reprod Biol 118:219-224 (Pubitemid 40093838)
2. Adams RH,Wilkinson GA,Weiss C, Diella F, Gale NW, Deutsch U, RisauW, Klein R (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295-306 (Pubitemid 29095801)
3. Agha-Majzoub R, Becker RP, Schraufnagel DE, Chan LS (2005) Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenicmouse model of atopic dermatitis. Microcirculation 12:455-476 (Pubitemid 41341789)
4. Ahmad SA, LiuW, JungYD, Fan F,Wilson M,ReinmuthN, Shaheen RM, BucanaCD, EllisLM (2001) The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res 61:1255-1259 (Pubitemid 34292536)
5. AlonT,HemoI, ItinA,Peer J, Stone JKeshetE(1995)Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028
6. Alva JA, Iruela-Arispe ML (2004) Notch signaling in vascular morphogenesis. Curr Opin Hematol 11:278-283 (Pubitemid 39120957)
7. Andries LJ, Brutsaert DL, Sys SU (1998) Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82:195-203 (Pubitemid 28080102)
8. Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, Tanaka F, Kamachi M, Aratake K,Nakamura H, IdaH, UetaniM,Kawakami A, EguchiK(2005) RS3PEsyndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis 64:1653-1655 (Pubitemid 41532054)
9. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, SchattemanG, IsnerJM(1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967 (Pubitemid 27087709)
10. Asahara T, Takahashi T, Masuda H, Kalka C Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrowderived endothelial progenitor cells. EMBO J 18:3964-3972 (Pubitemid 29335849)
11. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, DeMol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr- Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, ShibuyaM, Collen D, Conway EM, Carmeliet P (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:936-943 (Pubitemid 36889938)
12. Autiero M, De Smet F, Claes F, Carmeliet P (2005) Role of neural guidance signals in blood vessel navigation. Cardiovasc Res 65:629-638 (Pubitemid 40138983)
13. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P,MazarakisND(2004)VEGFdeliverywith retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429:413-417 (Pubitemid 38715132)
14. Baffert F, Le T, Sennino B, Thurston G, Kuo C, Hu-Lowe D, McDonald DM (2005) Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290:H547-H559
15. Bai TR, Knight DA (2005) Structural changes in the airways in asthma: observations and consequences. Clin Sci (Lond) 108:463-477 (Pubitemid 40827554)
16. Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P,CollenD, Foidart JM(1998)Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4:923-928 (Pubitemid 28364031)
17. BajouK,MassonV,GerardRD,Schmitt PM,AlbertV,PrausM, LundLR, FrandsenTL, Brunner N, Dano K, FusenigNE,Weidle U, Carmeliet G, Loskutoff D, CollenD, Carmeliet P, Foidart JM Noel A (2001) The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152:777-784 (Pubitemid 34280162)
18. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Yla-Herttuala S, Jackson DG, Alitalo K, McDonald DM (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115:247-257 (Pubitemid 40385467)
19. Barillari G, Ensoli B (2002) Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 15:310-326 (Pubitemid 34303768)
20. Bayless KJ, Salazar R, Davis GE (2000) RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)β(3) and alpha(5)β(1 integrins. Am J Pathol 156:1673-1683 (Pubitemid 30646705)
21. Beaudry P, Force J, Naumov GN, Wang A, Baker CH, Ryan A, Soker S, Johnson BE, Folkman J, Heymach JV (2005) Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res 11:3514-3522 (Pubitemid 40627906)
22. Bedell VM,Yeo SY, ParkKW, Chung J, Seth P, ShivalingappaV, Zhao J, Obara T, SukhatmeVP, Drummond IA, Li DY, Ramchandran R (2005) roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A 102:6373-6378 (Pubitemid 40617450)
23. Begbie ME,Wallace GM, Shovlin CL (2003) Hereditary haemorrhagic telangiectasia (Osler- Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 79:18-24 (Pubitemid 36237873)
24. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E (2002) Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21:5951-5955 (Pubitemid 35007248)
25. Bergers G, Hanahan D (2002) Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice. Cold Spring Harb Symp Quant Biol 67:293-300 (Pubitemid 36775523)
26. BergersG, BrekkenR,McMahonG,Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744
27. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287-1295 (Pubitemid 36554699)
28. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, Napolitano M (2003) Analysis of the role of chemokines in angiogenesis. J Immunol Methods 273:83-101 (Pubitemid 36078465)
29. Betsholtz C (2004) Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15:215-228 (Pubitemid 38781047)
30. Bianco R, Troiani T, Tortora G, Ciardiello F (2005) Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer 12 Suppl 1:S159-171 (Pubitemid 41395423)
31. Blann AD,Woywodt A, Bertolini F, Bull TM, Buyon JP Clancy RM, Haubitz M, Hebbel RP, Lip GY,Mancuso P, Sampol J, Solovey A, Dignat-George F (2005) Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 93:228-235 (Pubitemid 40253726)
32. BocciG,Man S,Green SK, FranciaG, Ebos JM, duManoir JM,Weinerman A,EmmeneggerU, Ma L, Thorpe P, Davidoff A, Huber J, Hicklin DJ, Kerbel RS (2004) Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. Cancer Res 64:6616-6625 (Pubitemid 39297922)
33. Boudier HA (1999) Arteriolar and capillary remodelling in hypertension. Drugs 58 Spec No 1:37-40 (Pubitemid 29443878)
34. Branca MA (2005) Multi-kinase inhibitors create buzz at ASCO. Nat Biotechnol 23:639 (Pubitemid 41716349)
35. Brower V (2003) Evidence of efficacy: researchers investigating markers for angiogenesis inhibitors. J Natl Cancer Inst 95:1425-1427
36. Brown LA, Rodaway AR, Schilling TF, Jowett T, Ingham PW, Patient RK, Sharrocks AD (2000) Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech Dev 90: 237-252 (Pubitemid 30042929)
37. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, DetmarM(1995) Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749
38. Broxterman HJ, Lankelma J,Hoekman K (2003) Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences. Drug Resist Updat 6:111-127 (Pubitemid 36890336)
39. Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, SchaperW(2001) GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159:343-356 (Pubitemid 33127248)
40. Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, Mames RN, Segal MS, GrantMB, ScottEW(2005) SDF-1 isbothnecessary andsufficient topromoteproliferative retinopathy. J Clin Invest 115:86-93 (Pubitemid 40385508)
41. Caldwell RB, BartoliM, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW(2005) Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 6:511-524 (Pubitemid 40916276)
42. Campochiaro PA (2004) Ocular neovascularisation and excessive vascular permeability. Expert Opin Biol Ther 4:1395-1402 (Pubitemid 39222973)
43. Cao R, Brakenhielm E, Pawliuk R,WariaroD, Post MJ,Wahlberg E, Leboulch P, Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9:604-613 (Pubitemid 36597108)
44. Caplice NM, Bunch TJ, Stalboerger PG,Wang S, Simper D,Miller DV, Russell SJ, LitzowMR, Edwards WD (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100:4754-4759 (Pubitemid 36457802)
45. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO (2001) Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 276:26516-26525
46. Carmeliet P (1999) Developmental biology. Controlling the cellular brakes. Nature 401: 657-658
47. Carmeliet P (2000a) Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis? Circ Res 87:176-178 (Pubitemid 30626422)
48. Carmeliet P (2000b) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395 (Pubitemid 30208155)
49. Carmeliet P (2002) Integrin indecision. Nat Med 8:14-16 (Pubitemid 34101713)
50. Carmeliet P (2003a) Angiogenesis in health and disease. Nat Med 9:653-660 (Pubitemid 36749213)
51. Carmeliet P (2003b) Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 4:710-720 (Pubitemid 37046138)
52. Carmeliet P, Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436:193-200 (Pubitemid 41021263)
53. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, VandenhoeckA, HarpalK, Eberhardt C, Declercq C, Pawling J,Moons L, CollenD, RisauW, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439 (Pubitemid 26102719)
54. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E (1999a) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147-157 (Pubitemid 29344903)
55. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I,Mattot V, Perriard JC, Dewerchin M, FlamengW, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT (1999b) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5:495-502 (Pubitemid 29220207)
56. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, ScholzD, Acker T,DiPalma T, Dewerchin M,Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583 (Pubitemid 32448325)
57. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004 Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864 (Pubitemid 39070860)
58. Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, Koh GY (2000 Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20:2573-2578
59. ChambersRC, Leoni P,KaminskiN, Laurent GJ,HellerRA(2003) Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 162:533-546 (Pubitemid 36267860)
60. Chang E, Yang J, Nagavarapu U, Herron GS (2002) Aging and survival of cutaneous microvasculature. J Invest Dermatol 118:752-758 (Pubitemid 34526536)
61. Chen JN, Haffter P, Odenthal J, Vogelsang E, Brand M, van Eeden FJ, Furutani-Seiki M, Granato M, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, Nusslein-Volhard C (1996) Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development 123:293-302 (Pubitemid 27056756)
62. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 100:10623-10628 (Pubitemid 37140079)
63. Childs S, Chen JN, Garrity DM, Fishman MC (2002) Patterning of angiogenesis in the zebrafish embryo. Development 129:973-982 (Pubitemid 34874121)
64. Choi K (2002) The hemangioblast: a common progenitor of hematopoietic and endothelial cells. J Hematother Stem Cell Res 11:91-101 (Pubitemid 34163773)
65. Cleaver O, Krieg PA (1998) VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 125:3905-3914 (Pubitemid 28488365)
66. Cohen FM, Kuwatsuru R, Shames DM, NeuderM,Mann JS, Vexler V, RosenauW, Brasch RC (1994) Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol 29:970-977
67. Collins JM(2005) Imaging and other biomarkers in early clinical studies: one step at a time or re-engineering drug development? J Clin Oncol 23:5417-5419
68. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K,Moons L, Collen D, Carmeliet P (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8:702-710 (Pubitemid 34778723)
69. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382-1397 (Pubitemid 29270244)
70. Creazzo TL, Godt RE, Leatherbury L, Conway SJ, Kirby ML (1998) Role of cardiac neural crest cells in cardiovascular development. Annu Rev Physiol 60:267-286 (Pubitemid 28157874)
71. Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, PatelM, Schwartz SD (2005) A phase II randomized doublemasked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112:1747-1757 (Pubitemid 41400011)
72. de Bruijn MF, Speck NA, Peeters MC, Dzierzak E (2000) Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J 19: 2465-2474 (Pubitemid 30323536)
73. de la Torre JC (2004) Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26:517-524 (Pubitemid 38879234)
74. Derhaag JG, Duijvestijn AM, Emeis JJ, EngelsW, van Breda Vriesman PJ (1996) Production and characterization of spontaneous rat heart endothelial cell lines. Lab Invest 74: 437-451 (Pubitemid 26072085)
75. Derhaag JG, DuijvestijnAM,VanBredaVriesman PJ (1997) HeartECrespondheterogeneous on cytokine stimulation in ICAM-1 and VCAM-1, but not in MHC expression. A study with 3 rat heart endothelial cell (RHEC) lines. Endothelium 5:307-319 (Pubitemid 28177015)
76. Dettman RW, Denetclaw W Jr, Ordahl CP, Bristow J (1998) Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 193:169-181 (Pubitemid 28113560)
77. Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Noel A, Foidart JM (2002) The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J 16:147-154 (Pubitemid 34113008)
78. Dickson BJ (2002) Molecular mechanisms of axon guidance. Science 298:1959-1964 (Pubitemid 35425245)
79. Dimmeler S, Haendeler J, Rippmann V, Nehls M, Zeiher AM (1996) Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett 399:71-74 (Pubitemid 27007954)
80. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Muller- Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95:109-116. (Pubitemid 38931842)
81. Dong J, Grunstein J, Tejada M, Peale F, Frantz G, LiangWC, BaiW, Yu L, Kowalski J, Liang X, Fuh G, Gerber HP, Ferrara N (2004) VEGF-null cells require PDGFR alpha signalingmediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800-2810 (Pubitemid 39013552)
82. DonovanMJ, LinMI,Wiegn P, Ringstedt T,Kraemer R, Hahn R, Wang S, Ibanez CF,Rafii S, Hempstead BL (2000) Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127:4531-4540
83. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388-1393 (Pubitemid 30152012)
84. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.Mol Cell 4:915-924 (Pubitemid 30054898)
85. Ema M, Faloon P, Zhang WJ, Hirashima M, Reid T, Stanford WL, Orkin S, Choi K, Rossant J (2003) Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 17:380-393 (Pubitemid 36182197)
86. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE (2003) Glomerular-specific alterations ofVEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111:707-716 (Pubitemid 36278589)
87. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M (2001) Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61:2145-2153 (Pubitemid 32692040)
88. FehlingHJ,LacaudG,KuboA,KennedyM,RobertsonS,Keller G,KouskoffV(2003) Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130:4217-4227 (Pubitemid 37063436)
89. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodes J, Bosch J (2005) Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 43:98-103 (Pubitemid 40805279)
90. Ferrara N (2000a) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15-35; discussion 35-16
91. Ferrara N (2000b) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11:617-624
92. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795-803 (Pubitemid 37328914)
93. Ferrara N, Kerbel R (2005) Angiogenesis as a therapeutic target. Nature 438:967-974 (Pubitemid 43093963)
94. Ferrara N, Carver-Moore K, ChenH, DowdM, Lu L, O'shea KS, Powell-Braxton L,Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442 (Pubitemid 26102720)
95. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004a) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391-400 (Pubitemid 38618122)
96. Ferrara N, LeCouter J, Lin R, Peale F (2004b) EG-VEGF and Bv8: a novel family of tissuerestricted angiogenic factors. Biochim Biophys Acta 1654:69-78 (Pubitemid 38230932)
97. Ferrara N, Hillan KJ, Novotny W (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333:328-335 (Pubitemid 40848295)
98. Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
99. Frid MG,KaleVA, StenmarkKR(2002)Mature vascular endotheliumcan give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. CircRes 90:1189-1196 (Pubitemid 34786904)
100. Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, Chatterjee K, Garkavtsev I, JainRK(2003) Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 93:e88-97
101. GaleNW,YancopoulosGD(1999)Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055-1066 (Pubitemid 29233137)
102. GaleNW,ThurstonG,HackettSF,RenardR,WangQ,McClainJ,MartinC,WitteC,WitteMH, JacksonD, Suri C, Campochiaro PA,Wiegand SJ, YancopoulosGD(2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3:411-423
103. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87:603-607
104. Garcia-BarrosM, Paris F, Cordon-Cardo C, LydenD, Rafii S,Haimovitz-Friedman A, Fuks Z, Kolesnick R (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-1159 (Pubitemid 36583102)
105. Gealekman O, Brodsky SV, Zhang F, Chander PN, Friedli C, Nasjletti A, Goligorsky MS (2004) Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. Kidney Int 66:2337-2347 (Pubitemid 41115298)
106. Gendron RL, Adams LC, Paradis H(2000) Tubedown-1, a novel acetyltransferase associated with blood vessel development. Dev Dyn 218:300-315 (Pubitemid 30349641)
107. Gennaro G, Menard C, Michaud SE, Rivard A (2003) Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. Circulation 107:230-233 (Pubitemid 36135216)
108. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N (1999) VEGF is required for growth and survival in neonatal mice. Development 126:1149-1159 (Pubitemid 29182112)
109. Gerety SS, Anderson DJ (2002) Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129:1397-1410 (Pubitemid 34874161)
110. Gerety SS, Wang HU, Chen ZF, Anderson DJ (1999) Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4:403-414 (Pubitemid 29499793)
111. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161:1163-1177 (Pubitemid 36870177)
112. Gira AK, Brown LF,Washington CV, Cohen C, Arbiser JL (2004) Keloids demonstrate highlevel epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 50:850-853 (Pubitemid 38685763)
113. Gittenberger-de Groot AC, DeRuiter MC, Bergwerff M, Poelmann RE (1999) Smoothmuscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 19:1589-1594 (Pubitemid 29323815)
114. Gohongi T, Fukumura D, Boucher Y, Yun CO, Soff GA, Compton C, Todoroki T, Jain RK (1999) Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med 5:1203-1208 (Pubitemid 29474428)
115. Gosepath J, Brieger J, Lehr HA, Mann WJ (2005) Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps.AmJ Rhinol 19:7-13 (Pubitemid 40443998)
116. GoumansMJ,Valdimarsdottir G, Itoh S,Rosendahl A, Sideras P, tenDijke P (2002) Balancing the activation state of the endotheliumvia two distinct TGF-beta type I receptors. EMBO J 21:1743-1753 (Pubitemid 34614630)
117. Green CJ, Lichtlen P,Huynh NT, Yanovsky M, Laderoute KR, SchaffnerW,Murphy BJ (2001) Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 612696-2703 (Pubitemid 32685857)
118. Groothuis PG, Nap AW, Winterhager E, Grummer R (2005) Vascular development in endometriosis. Angiogenesis 8:147-156 (Pubitemid 41712844)
119. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Keshet E (2005) VEGF-induced adult neovascularization depends on SDF-1-mediated retention of bonemarrow derived accessory cells. Cell 124:175-189
120. Gu C, Yoshida Y, Livet J, Reimert DV,Mann F,Merte J, Henderson CE, Jessell TM, Kolodkin AL, Ginty DD (2005) Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307:265-268 (Pubitemid 40116243)
121. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y,Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M (2005) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65:5864-5871 (Pubitemid 40911192)
122. Guo DQ, Wu LW, Dunbar JD, Ozes ON, Mayo LD, Kessler KM, Gustin JA, Baerwald MR, Jaffe EA, Warren RS, Donner DB (2000) Tumor necrosis factor employs a proteintyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 275:11216-11221 (Pubitemid 30212766)
123. Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro PA (2000) Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol 184:275-284 (Pubitemid 30625490)
124. Haigh JJ, Gerber HP, Ferrara N, Wagner EF (2000) Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 127:1445-1453 (Pubitemid 30232595)
125. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated byMMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3:589-601 (Pubitemid 36808653)
126. Harada K, Lu S Chisholm DM, Syrjanen S, Schor AM(2000) Angiogenesis and vasodilation in skin warts. Association with HPV infection. Anticancer Res 20:4519-4523 (Pubitemid 32141813)
127. HatoumOA,BinionDG,GuttermanDD(2005) Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest 35:599-609 (Pubitemid 41406724)
128. HattoriK,Dias S,HeissigB,HackettNR,LydenD, TatenoM,HicklinDJ, ZhuZ,WitteL, Crystal RG,Moore MA, Rafii S (2001) Vascular endothelial growth factor and angiopoietin-1. stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005-1014 (Pubitemid 32436194)
129. Hattori K, Heissig B,Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P,Witte L, Hendrikx J,HackettNR,CrystalRG,Moore MA,Werb Z, LydenD, Rafii S (2002) Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 8:841-849
130. Hausman MR, Rinker BD (2004) Intractable wounds and infections: the role of impaired vascularity and advanced surgical methods for treatment. Am J Surg 187:44S-55S. (Pubitemid 38625988)
131. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, Schaper W (2002) Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 283:H2411-2419 (Pubitemid 35345945)
132. Helisch A, Schaper W (2003) Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10:83-97 (Pubitemid 39004238)
133. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047-3055 (Pubitemid 29378170)
134. Herbst RS, MullaniNA, Davis DW, Hess KR,McConkey DJ, Charnsangavej C, O'Reilly MS, KimHW, Baker C, Roach J, Ellis LM, Rashid A, Pluda J, Bucana C,Madden TL, Tran HT, Abbruzzese JL (2002) Development of biologic markers of
135. Herzog Y, Guttmann-Raviv N, Neufeld G (2005) Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation. Dev Dyn 232:1047-1055 (Pubitemid 40463957)
136. Hewett P, Nijjar S, Shams M, Morgan S, Gupta J, Ahmed A (2002) Down-regulation of angiopoietin-1 expression in menorrhagia. Am J Pathol 160:773-780 (Pubitemid 34224566)
137. Heymans S, LuttunA, Nuyens D, Theilmeier G, Creemers E, Moons L,DyspersinGD,Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, BorgersM, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135-1142 (Pubitemid 29474417)
138. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600 (Pubitemid 36204953)
139. Hillebrands JL,KlatterFA, van denHurkBM,PopaER,NieuwenhuisP,Rozing J (2001)Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 107:1411-1422 (Pubitemid 32522035)
140. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J (2002) Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 8:194-195 (Pubitemid 34250078)
141. Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK (2002) Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 105:1639-1641 (Pubitemid 34298605)
142. Holash J,Maisonpierre PC,ComptonD, Boland P,AlexanderCR, ZagzagD,YancopoulosGD, Wiegand SJ (1999) Vessel cooption regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998 (Pubitemid 29309448)
143. Honma Y, Araki T, Gianino S, Bruce A, Heuckeroth R, Johnson E, Milbrandt J (2002) Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron 35:267-282 (Pubitemid 34876730)
144. Hood JD,ChereshDA(2002)Role of integrins in cell invasion and migration.NatRev Cancer 2:91-100 (Pubitemid 37328796)
145. Huang J, SofferSZ,KimES,McCruddenKW,NewT,ManleyCA,MiddlesworthW,O'TooleK, Yamashiro DJ, Kandel JJ (2004) Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis. Mol Cancer Res 2:36-42. (Pubitemid 38167106)
146. Huber AB, Kolodkin AL, Ginty DD, Cloutier JF (2003) Signaling at the growth cone: ligandreceptor complexes and the control of axon growth and guidance. Annu Rev Neurosci 26:509-563 (Pubitemid 37064943)
147. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK (2003) Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88:2889-2899 (Pubitemid 36733546)
148. Humbert M, Trembath RC (2002) Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J 20:741-749
149. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342 (Pubitemid 38702844)
150. Hynes RO (2002) A reevaluation of integrins as regulators of angiogenesis. Nat Med 8: 918-921 (Pubitemid 35033683)
151. InceWL, JubbAM,Holden SN,Holmgren EB, Tobin P, SridharM,HurwitzHI, Kabbinavar F, Novotny WF, Hillan KJ, Koeppen H (2005) Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab. J Natl Cancer Inst 97:981-989 (Pubitemid 41430564)
152. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath ES (2001) Expression of vascular endothelial growth factor receptors in smoothmuscle cells. J Cell Physiol 188:359-368 (Pubitemid 32777178)
153. Isner JM (2002) Myocardial gene therapy. Nature 415:234-239 (Pubitemid 34059530)
154. Iwami Y,Masuda H, Asahara T (2004) Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med 8:488-497 (Pubitemid 44145481)
155. JacksonC(2002)Matrix metalloprot einasesandan gioge nesis.Curr Opin Nephrol Hypertens 11:295-299
156. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685-693 (Pubitemid 36749217)
157. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58-62 (Pubitemid 40093472)
158. Jain RK, Munn LL (2000) Leaky vessels? Call Ang1! Nat Med 6:131-132
159. Jenkinson L, Bardhan KD, Atherton J, Kalia N (2002) Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines. Dig Dis Sci 47:1857-1862 (Pubitemid 34833220)
160. Jennens RR, Rosenthal MA, Lindeman GJ, Michael M (2004) Complete radiological and metabolic response of metastatic renal cell carcinomato SU5416 (semaxanib) in a patient with probable von Hippel-Lindau syndrome. Urol Oncol 22:193-196 (Pubitemid 38950624)
161. Jesmin S, Hattori Y, Togashi H, Ueno K, Yoshioka M, Sakuma I (2005) Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats. Mol Cell Biochem 272:63-73 (Pubitemid 40867366)
162. Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T (2005) Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol 53:35-69 (Pubitemid 39656109)
163. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY (2005) Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132:5199-5209 (Pubitemid 43020175)
164. Kahlon R, Shapero J, Gotlieb AI (1992) Angiogenesis in atherosclerosis. Can J Cardiol 8:60-64
165. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN (2002) CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12:371-384 (Pubitemid 34743219)
166. Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O'Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ, McDonald DM (2005) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560-H576
167. Kamihata H,Matsubara H,NishiueT, FujiyamaS,AmanoK, IbaO, ImadaT, IwasakaT(2002) Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 22:1804-1810 (Pubitemid 35315765)
168. Kang DH, Anderson S, KimYG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ (2001) Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37:601-611 (Pubitemid 32195301)
169. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106:1311-1319
170. Kearney JB, Ambler CA, Monaco KA, Johnson N, Rapoport RG, Bautch VL (2002) Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 99:2397-2407 (Pubitemid 34525425)
171. Kennedy M, Firpo M, Choi K, Wall C, Robertson S, Kabrun N, Keller G (1997) A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386: 488-493 (Pubitemid 27164073)
172. Kerbel RS, Yu J, Tran J,Man S,Viloria-Petit A,KlementG, Coomber BL, Rak J (2001) Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer Metastasis Rev 20:79-86 (Pubitemid 34074682)
173. Khurana R,Moons L, Shafi S, Luttun A, Collen D,Martin JF, Carmeliet P, Zachary IC (2005) Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111:2828-2836 (Pubitemid 40791556)
174. Kim JS, Kim JM, Jung HC, Song IS (2004) Helicobacter pylori down-regulates the receptors of vascular endothelial growth factor and angiopoietin in vascular endothelial cells: implications in the impairment of gastric ulcer healing. Dig Dis Sci 49:778-786 (Pubitemid 38870204)
175. Kirk SL, Karlik SJ (2003) VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 21:353-363 (Pubitemid 37420080)
176. Kirmaz C, Ozbilgin K Yuksel H, Bayrak P, Unlu H, Giray G, Kiliccioglu B (2004) Increased expression of angiogenic markers in patientswith seasonal allergic rhinitis.EurCytokine Netw 15:317-322 (Pubitemid 40127656)
177. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S (2001) Neovascularization of ischemicmyocardium by human bonemarrow- derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436 (Pubitemid 32298545)
178. Konno S, Iizuka M, Yukawa M, Sasaki K, Sato A, Horie Y, Nanjo H, Fukushima T, Watanabe S (2004) Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease. J Gastroenterol 39:931-939 (Pubitemid 39490169)
179. Kostoulas G,Lang A,Nagase H, BaiciA(1999) Stimulationof angiogenesis throughcathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 455: 286-290 (Pubitemid 29333053)
180. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T (2002) Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166:382-385 (Pubitemid 34864431)
181. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM (1994) Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25:1794-1798 (Pubitemid 24274974)
182. Kubis N, Richer C, Domergue V, Giudicelli JF, Levy BI (2002) Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt/). J Hypertens 20:1581-1587 (Pubitemid 34921182)
183. Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G, Ye H, Ginty DD (2004) A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell 118:243-255 (Pubitemid 38962579)
184. Lainer DT, Brahn E (2005) New antiangiogenic strategies for the treatment of proliferative synovitis. Expert Opin Investig Drugs 14:1-17
185. Lambert V, Munaut C, Noel A, Frankenne F, Bajou K, Gerard R, Carmeliet P, DefresneMP, Foidart JM, Rakic JM (2001) Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J 15:1021-1027 (Pubitemid 32290790)
186. Lambrechts D, Carmeliet P (2004) Medicine: genetic spotlight on a blood defect. Nature 427:592-594 (Pubitemid 38248463)
187. LambrechtsD, StorkebaumE,MorimotoM,Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, RobberechtW, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394 (Pubitemid 36935331)
188. Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100:4495-4501 (Pubitemid 35429690)
189. Lawson ND, Weinstein BM (2002) Arteries and veins: making a difference with zebrafish. Nat Rev Genet 3:674-682 (Pubitemid 34984256)
190. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA Weinstein BM (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675-3683 (Pubitemid 32998917)
191. Lawson ND, Vogel AM, Weinstein BM (2002) sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3:127-136 (Pubitemid 34778401)
192. Lebrin F, Deckers M, Bertolino P, Ten Dijke P (2005) TGF-beta receptor function in the endothelium. Cardiovasc Res 65:599-608
193. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877-884 (Pubitemid 32821726)
194. LeCouter J, Lin R, Ferrara N (2002) Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. Nat Med 8:913-917 (Pubitemid 35033682)
195. Lecouter J, Lin R, Ferrara N (2004) EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype, and function. Ann N Y Acad Sci 1014:50-57 (Pubitemid 38594790)
196. Lee JW, Juliano R (2004) Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 17:188-202 (Pubitemid 39137065)
197. Leong TT, Fearon U, Veale DJ (2005) Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis. Curr Rheumatol Rep 7:325-329
198. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683 (Pubitemid 38364626)
199. Li J, Han X, Jiang J, Zhong R,Williams GM, Pickering JG, Chow LH (2001) Vascular smooth muscle cellsof recipientoriginmediate intimal expansionafter aortic allotransplantation in mice. Am J Pathol 158:1943-1947 (Pubitemid 32545177)
200. Li J, Yu X, PanW, Unger RH (2002) Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 282:E1334-1341 (Pubitemid 34654703)
201. Li X, Tjwa M, Moons L, Fons P, Noel A, Ny A, Zhou JM, Lennartsson J, Li H, Luttun A, Ponten A, Devy L, Bouche A, Oh H,Manerveld A, Blacher S, Communi D, Savi P, Bono F, Dewerchin M, Foidart JM, Autiero M, Herbert JM, Collen D, Heldin CH, Eriksson U, Carmeliet P (2005) Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest 115:118-127 (Pubitemid 40385512)
202. Liang D, Chang JR, Chin AJ, Smith A, Kelly C,Weinberg ES, Ge R (2001) The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev 108:29-43 (Pubitemid 32918175)
203. LiaoW, Ho CY, Yan YL, Postlethwait J, Stainier DY (2000) Hhex and scl function in parallel to regulate early endothelial and blood differentiation in zebrafish. Development 127: 4303-4313
204. Lindahl P, HellstromM, Kalen M, Betsholtz C (1998) Endothelial- perivascular cell signaling in vascular development: lessons from knockout mice. Curr Opin Lipidol 9:407-411 (Pubitemid 28495549)
205. Lindahl P, BostromH, Karlsson L,HellstromM,Kalen M, Betsholtz C (1999) Role of plateletderived growth factors in angiogenesis and alveogenesis. Curr Top Pathol 93:27-33
206. Liu G, Rugo HS,Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT Jr, Charnsangavej C, Park JW, Ashton EA, Steinfeldt HM, Pithavala YK, Reich SD, HerbstRS(2005)Dynamic contrast-enhancedmagnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol 23:5464-5473
207. Long DA, MuW, Price KL, Johnson RJ (2005) Blood vessels and the aging kidney. Nephron Exp Nephrol 101:e95-99 (Pubitemid 41540697)
208. Lu X, Le Noble F, Yuan L, Jiang Q, De Lafarge B, Sugiyama D, Breant C, Claes F, De Smet F, Thomas JL, Autiero M, Carmeliet P, Tessier-Lavigne M, Eichmann A (2004) The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432:179-186 (Pubitemid 39545842)
209. Luttun A, DewerchinM,CollenD, CarmelietP(2000) The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis,myocardial ischemia, and stroke: insights from genetic studies. Curr Atheroscler Rep 2:407-416
210. Luttun A, Tjwa M,Moons L,Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA,Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:831-840
211. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194-1201 (Pubitemid 33063774)
212. Mackiewicz Z, Sukura A, Povilenaite D, Ceponis A, Virtanen I, Hukkanen M, Konttinen YT (2002) Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol 20:641-646 (Pubitemid 35243776)
213. Maes C, Carmeliet P,Moermans K, Stockmans I, Smets N, Collen D, Bouillon R, Carmeliet G (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111: 61-73 (Pubitemid 34136979)
214. Magnon C, GalaupA,Mullan B,RouffiacV, Bouquet C Bidart JM,Griscelli F,Opolon P, PerricaudetM( 2005) Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Cancer Res 65:4353-4361. (Pubitemid 40775674)
215. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
216. Martinez P, Esbrit P, Rodrigo A, Alvarez-Arroyo MV, Martinez ME (2002) Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Osteoporos Int 13:874-881 (Pubitemid 35364788)
217. Marx GM, Steer CB, Harper P, Pavlakis N, Rixe O, Khayat D (2002) Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock! J Clin Oncol 20:1446-1448 (Pubitemid 34260521)
218. Marx J (2005) Cancer. Encouraging results for second-generation antiangiogenesis drugs. Science 308:1248-1249 (Pubitemid 40746102)
219. Mattot V, Moons L, Lupu F, Chernavvsky D, Gomez RA, Collen D, Carmeliet P (2002) Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 13:1548-1560 (Pubitemid 34579244)
220. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE,Epstein FH, SukhatmeVP,KarumanchiSA(2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658 (Pubitemid 36278583)
221. McGrath-Morrow SA, Cho C, Zhen L, Hicklin DJ, Tuder RM (2005) Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development. Am J Respir Cell Mol Biol 32:420-427 (Pubitemid 40629327)
222. McNeel DG, Eickhoff J, Lee FT, King DM, Alberti D, Thomas JP, Friedl A, Kolesar J, Marnocha R, Volkman J, Zhang J, Hammershaimb L, Zwiebel JA, Wilding G (2005) Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res 11:7851-7860. (Pubitemid 41611630)
223. Medina J, Sanz-Cameno P, Garcia-Buey L, Martin-Vilchez S, Lopez-Cabrera M, Moreno- Otero R (2005) Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol 42:124-131 (Pubitemid 40038910)
224. Meeson AP, Argilla M, Ko K,Witte L, Lang RA (1999) VEGF deprivation-induced apoptosis is a component of programmed capillary regression. Development 126:1407-1415 (Pubitemid 29195230)
225. Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ,Dehio C (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18:363-374 (Pubitemid 29041945)
226. Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA,KlagsbrunM(1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146:233-242
227. Miao RQ, Agata J, Chao L, Chao J (2002) Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 100:3245-3252 (Pubitemid 35217074)
228. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005a) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172-187 (Pubitemid 40277367)
229. Miller KD, Sweeney CJ, Sledge GWJr (2005b) Can tumor angiogenesis be inhibited without resistance? EXS 94:95-112
230. Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, Lynch MP, Rueda BR, Chung DC (2005) Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 11:992-997 (Pubitemid 41294446)
231. Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marme D, Steward WP (2003) Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results fromtwo phase I studies. J Clin Oncol 21:3955-3964. (Pubitemid 46606209)
232. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. AmJ Pathol 160:985-1000 (Pubitemid 34224587)
233. Moyon D, Pardanaud L, Yuan L, Breant C, Eichmann A (2001) Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128:3359-3370 (Pubitemid 32910388)
234. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ (2002) Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109:693-705 (Pubitemid 34722266)
235. Nakajima Y, Mironov V, Yamagishi T, Nakamura H, Markwald RR (1997) Expression of smoothmuscle alpha-actin inmesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn 209:296-309 (Pubitemid 27282199)
236. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, Ishii T, Iida M, Sueishi K (2005) Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol 36:330-340 (Pubitemid 40591802)
237. Nasevicius A, Larson J, Ekker SC (2000) Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17:294-301 (Pubitemid 32051422)
238. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y (2002) The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12:13-19 (Pubitemid 34048706)
239. Neuhaus T, Stier S, Totzke G, Gruenewald E, Fronhoffs S, Sachinidis A, Vetter H, Ko YD (2003) Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif 3675-86 (Pubitemid 36532558)
240. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H (1998) Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757 (Pubitemid 28256742)
241. Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65:3967-3979 (Pubitemid 40775631)
242. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328 (Pubitemid 24324921)
243. O'Reilly MS, Boehm T, Shing Y, FukaiN, Vasios G, LaneWS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285 (Pubitemid 28015876)
244. Ohno A, Mitsui T, Endo I, Kunishige M, Sigekiyo T, Matsumoto T (2004) Dermatomyositis associated with Sjogren's syndrome: VEGF involvement in vasculitis. Clin Neuropathol 23:178-182 (Pubitemid 38993052)
245. OikeY, ItoY,HamadaK, ZhangXQ,MiyataK,AraiF, InadaT,ArakiK,NakagataN, TakeyaM, Kisanuki YY, Yanagisawa M, Gale NW, Suda T (2002) Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. Blood 100:1326-1333 (Pubitemid 34864288)
246. OkamotoR,UenoM,YamadaY,Takahashi N, Sano H, SudaT,TakakuraN(2005) Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 105:2757-2763 (Pubitemid 40446266)
247. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28:131-138 (Pubitemid 32538057)
248. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, RichardsonAL,WeinbergRA(2005) Stromalfibroblastspresent ininvasivehumanbreast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348 (Pubitemid 40692295)
249. Ostman A (2004) PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15:275-286 (Pubitemid 38781051)
250. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M (2003) A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 101:560-567 (Pubitemid 36077578)
251. Pahernik S,Harris AG, Schmitt-SodyM, Krasnici S, Goetz AE, Dellian M,Messmer K (2002) Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study. Br J Cancer 86:1622-1627 (Pubitemid 34628117)
252. Pardanaud L, Luton D, Prigent M, Bourcheix LM, Catala M, Dieterlen-Lievre F (1996) Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 122:1363-1371 (Pubitemid 26159627)
253. Park JE, Keller GA, Ferrara N (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326 (Pubitemid 24045761)
254. Park JW, Kerbel RS, Kelloff GJ, Barrett JC, Chabner BA, Parkinson DR, Peck J, Ruddon RW, Sigman CC, Slamon DJ (2004) Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development. Clin Cancer Res 10:3885-3896 (Pubitemid 38697625)
255. Park KW, Morrison CM, Sorensen LK, Jones CA, Rao Y, Chien CB,Wu JY, Urness LD, Li DY (2003) Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol 261:251-267 (Pubitemid 36993830)
256. Parker LH, SchmidtM, Jin SW, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DY, De Sauvage FJ, Ye W (2004) The endothelial-cell- derived secreted factor Egfl7 regulates vascular tube formation. Nature 428:754-758 (Pubitemid 38514720)
257. Patsouris E, Katsarou O, Korkolopoulou P, Kotsi P, Kouramba A, Androulaki A, Karafoulidou A (2004) Increased microvascular network in bone marrow of HIV-positive haemophilic patients. HIV Med 5:18-25 (Pubitemid 38219977)
258. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ,Williams M, Oz MC,Hicklin DJ,Witte L, Moore MA, Rafii S (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958 (Pubitemid 30062717)
259. Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43 (Pubitemid 27214687)
260. Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK (2001) Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells. Thromb Haemost 86:702-709 (Pubitemid 32743288)
261. Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, Brasch RC (1998)Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16:225-230 (Pubitemid 28211008)
262. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T,Martin S, van den Heuvel J,Weich H, Fernandez B, Golomb G, Carmeliet P, Schaper W, Clauss M (2003) VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 92:378-385 (Pubitemid 36298197)
263. PlankMJ, SleemanBD, Jones PF (2004) The role of the angiopoietins in tumour angiogenesis. Growth Factors 22:1-11 (Pubitemid 38660580)
264. Pufe T, Scholz-Ahrens KE, Franke AT, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Gluer CC (2003) The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone 33:869-876 (Pubitemid 37543563)
265. Qi JH, Ebrahem Q,Moore N,Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9:407-415 (Pubitemid 36460074)
266. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712 (Pubitemid 36749219)
267. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002) Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826-835 (Pubitemid 37328901)
268. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104:2084-2086 (Pubitemid 39297861)
269. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169 (Pubitemid 36297209)
270. Religa P, Bojakowski K,Maksymowicz M, Bojakowska M, Sirsjo A, Gaciong Z, OlszewskiW, Hedin U, Thyberg J (2002) Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation 74:1310-1315 (Pubitemid 35402603)
271. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337-346 (Pubitemid 34141807)
272. Reynolds LE,Wyder L, Lively JC, Taverna D, Robinson SD,Huang X, Sheppard D,Hynes RO, Hodivala-Dilke KM (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8:27-34 (Pubitemid 34101725)
273. Riba RD, Kaplan RN, Zacharoulis S, Jin DK, Costa D, Jun L, MacDonald DD, Bramley AH, Shido K, Kerns SA, Knowles J, Jensen KK, Shmelkov SV, Kato D, Port ER, Port JL, AltorkiN, Rafii S, LydenD(2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche VEGFR1+ hematopoietic bone marrowprogenitors initiate the premestatic niche. Nature 438:820-827 (Pubitemid 41753060)
274. Ribatti D, Vacca A, Nico B, Ria R, Dammacco F (2002) Cross-talk between hematopoiesis and angiogenesis signaling pathways. Curr Mol Med 2:537-543 (Pubitemid 34982186)
275. Rini BI, Sosman JA,Motzer RJ (2005) Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development. BJU Int 96:286-290 (Pubitemid 41097667)
276. RisauW(1995) Differentiation of endothelium. FASEB J 9:926-933
277. RisauW(1998) Development and differentiation of endothelium. Kidney Int Suppl 67:S3-6 (Pubitemid 28405671)
278. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355-363 (Pubitemid 29094086)
279. Rubin LL, Staddon JM(1999) The cell biology of the blood-brain barrier. Annu RevNeurosci 22:11-28 (Pubitemid 29144879)
280. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16:2684-2698
281. Ruoslahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2:83-90 (Pubitemid 37328795)
282. Ruoslahti E (2004) Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans 32:397-402 (Pubitemid 38813523)
283. Ruoslahti E, Rajotte D (2000) An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol 18:813-827 (Pubitemid 30365398)
284. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 99:10730-10735
285. Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S, Manova K, Mittal V, Benezra R (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277-289 (Pubitemid 37329792)
286. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M (2001) Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 7:382-383 (Pubitemid 32298513)
287. Sane DC, Anton L, Brosnihan KB (2004) Angiogenic growth factors and hypertension. Angiogenesis 7:193-201
288. Sata M Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8:403-409 (Pubitemid 34407037)
289. Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T, Shibuya M (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97:785-791 (Pubitemid 32113414)
290. Schrijvers BF, Flyvbjerg A, De Vriese AS (2004) The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65:2003-2017 (Pubitemid 38669987)
291. Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, Vriese AS (2005) A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrol Dial Transplant 21:324-329 (Pubitemid 43159984)
292. Senger DR, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, Detmar M (2002) The alpha(1)β(1) and alpha(2)β(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160:195-204 (Pubitemid 34052280)
293. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, Tessier-Lavigne M, Taniguchi M, Puschel AW, Bussolino F (2003) Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424:391-397 (Pubitemid 36917481)
294. Shaked Y, Bertolini F, Man S, RogersMS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS (2005) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7:101-111 (Pubitemid 40126386)
295. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M,Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
296. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K (2004) Adiponectin stimulates angiogenesis in response totissue ischemia throughstimulationof amp-activatedprotein kinase signaling. J Biol Chem 27928670-28674 (Pubitemid 38900150)
297. ShimWS, Teh M, Bapna A, Kim I, Koh GY, Mack PO, Ge R (2002) Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice. Exp Cell Res 279:299-309 (Pubitemid 35217558)
298. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779 (Pubitemid 32550062)
299. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108-2118 (Pubitemid 41134152)
300. Shoji W, Isogai S, Sato-Maeda M, Obinata M, Kuwada JY (2003) Semaphorin3a1 regulates angioblast migration and vascular development in zebrafish embryos. Development 130:3227-3236 (Pubitemid 36926959)
301. Shute J, Marshall L, Bodey K, Bush A (2003) Growth factors in cystic fibrosis-when more is not enough. Paediatr Respir Rev 4:120-127 (Pubitemid 36665480)
302. Simon AM, McWhorter AR (2002) Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251:206-220 (Pubitemid 35373744)
303. Simon R, Freidlin B, Rubinstein L, Arbuck SG, Collins J, Christian MC (1997) Accelerated titration designs for phase I clinical trials in oncology. J Natl Cancer Inst 89:1138-1147 (Pubitemid 27337928)
304. Simons M (2005) Angiogenesis: where do we stand now? Circulation 111:1556-1566 (Pubitemid 40470653)
305. SimperD, Stalboerger PG, Panetta CJ,Wang S, CapliceNM(2002)Smoothmuscle progenitor cells in human blood. Circulation 106:1199-1204 (Pubitemid 34988636)
306. Song S,EwaldAJ, StallcupW,WerbZ,BergersG(2005)PDGFRbeta+ perivascularprogenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870-879 (Pubitemid 41486287)
307. Sounni NE, Devy L,HajitouA, Frankenne F,Munaut C, GillesC, Deroanne C, Thompson EW, Foidart JM,NoelA (2002) MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16555-564 (Pubitemid 34273239)
308. Stalmans I,NgYS,RohanR,FruttigerM, BoucheA,YuceA, FujisawaH,HermansB, ShaniM, Jansen S, Hicklin D, Anderson DJ, Gardiner T, Hammes HP, Moons L, Dewerchin M, Collen D, Carmeliet P, D'Amore PA (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109:327-336 (Pubitemid 34141806)
309. Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, Von Der Ohe M, SwillenA,Maes C, GewilligM,MolinDG, HellingsP, Boetel T, HaardtM,CompernolleV, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-De Groot AC, Scambler P, Morrow B, Driscol DA, Moons L, Esguerra CV, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway SJ, Carmeliet P (2003) VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med 9:173-182
310. Stoll BR, Migliorini C, Kadambi A, Munn LL, Jain RK (2003) A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy. Blood 102:2555-2561 (Pubitemid 37193595)
311. StorkebaumE, Carmeliet P (2004) VEGF: a critical player in neurodegeneration. JClin Invest 113:14-18
312. Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943-954 (Pubitemid 39273068)
313. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, RobberechtW, Conway EM, Collen D, Moons L, Carmeliet P (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8:85-92 (Pubitemid 41236736)
314. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A 100:4766-4771 (Pubitemid 36457804)
315. Sudhakar A,Nyberg P,KeshamouniVG,MannamAP, Li J, SugimotoH,CosgroveD, KalluriR (2005) Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 115:2801-2810 (Pubitemid 41434407)
316. SuriC, Jones PF,PatanS,Bartunkova S,MaisonpierrePC,Davis S, SatoTN,YancopoulosGD (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180 (Pubitemid 27010101)
317. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD (1998) Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471 (Pubitemid 28483672)
318. Szekanecz Z, Gaspar L, Koch AE (2005) Angiogenesis in rheumatoid arthritis. Front Biosci 10:1739-1753 (Pubitemid 40529034)
319. Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M, Suda T (2000) A role for hematopoietic stem cells in promoting angiogenesis. Cell 102:199-209
320. Tamaki T, Akatsuka A, Ando K, Nakamura Y, Matsuzawa H, Hotta T, Roy RR, Edgerton VR (2002) Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157:571-577 (Pubitemid 34839786)
321. Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD (2004a) Capillary regression in vascular endothelial growth factor-deficient skeletalmuscle. Physiol Genomics 18:63-69 (Pubitemid 39319487)
322. Tang K, Rossiter HB,Wagner PD, Breen EC (2004b) Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 97:1559-1566; discussion 1549 (Pubitemid 39299378)
323. Taylor PC, Sivakumar B (2005) Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 17:293-298 (Pubitemid 40616575)
324. Tepper OM, GalianoRD, Capla JM, Kalka C, Gagne PJ, JacobowitzGR, Levine JP, Gurtner GC (2002)Humanendothelial progenitor cells fromtype II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786 (Pubitemid 35396976)
325. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J,McDonald DM, Yancopoulos GD (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6:460-463 (Pubitemid 30208166)
326. Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q (2004) Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427:640-645 (Pubitemid 38248484)
327. Tong RT, Boucher Y, Kozin SV,Winkler F,Hicklin DJ, Jain RK (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64: 3731-3736 (Pubitemid 38697278)
328. Tordjman R, Delaire S, Plouet J, Ting S, Gaulard P, Fichelson S, Romeo PH, Lemarchandel V (2001) Erythroblasts are a source of angiogenic factors. Blood 97:1968-1974 (Pubitemid 32239075)
329. Torres-Vazquez J, Gitler AD, Fraser SD, Berk JD, Van NP, Fishman MC, Childs S, Epstein JA, Weinstein BM (2004) Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell 7:117-123 (Pubitemid 39172693)
330. Tsao PN,Wei SC, ChouHC, Su YN, Chen CY,Hsieh FJ,HsiehWS (2005)Vascular endothelial growth factor in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 39:461-465
331. Tsukita S, Furuse M (1999) Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 9:268-273 (Pubitemid 29305516)
332. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM (1997) Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96:2667-2674 (Pubitemid 27451360)
333. vanCruijsen H, Giaccone G,HoekmanK(2005)Epidermal growth factor receptorandangiogenesis: opportunities for combined anticancer strategies. Int J Cancer 117: 883-888 (Pubitemid 41688561)
334. van den Driesche S, Mummery CL,Westermann CJ (2003) Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res 58:20-31 (Pubitemid 36351619)
335. vanRoyen N,Hoefer I, Buschmann I,Heil M,Kostin S, Deindl E,Vogel S,KorffT,AugustinH, Bode C, Piek JJ, SchaperW(2002) Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J 16:432-434
336. Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA,Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190 (Pubitemid 27010102)
337. Viloria-Petit AM, Kerbel RS (2004) Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies. Int J Radiat Oncol Biol Phys 58:914-926 (Pubitemid 38221151)
338. Visconti RP, Richardson CD, Sato TN (2002) Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A 99:8219-8224 (Pubitemid 34651033)
339. Visvader JE, Fujiwara Y, Orkin SH (1998) Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 12:473-479 (Pubitemid 28101010)
340. Voelkel NF,Cool C,Taraceviene-Stewart L, GeraciMW,YeagerM,BullT,KasperM, TuderRM (2002) Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Crit Care Med 30:S251-256 (Pubitemid 34507999)
341. Vokes SA, Krieg PA (2002) Endoderm is required for vascular endothelial tube formation, but not for angioblast specification. Development 129:775-785 (Pubitemid 34863837)
342. Vokes SA,YatskievychTA,Heimark RL,McMahon J,McMahonAP,Antin PB,KriegPA(2004) Hedgehog signaling is essential for endothelial tube formation during vasculogenesis. Development 131:4371-4380 (Pubitemid 39276203)
343. Voskas D, Jones N, Van Slyke P, Sturk C, ChangW,Haninec A, Babichev YO, Tran J,Master Z, Chen S, Ward N, Cruz M, Jones J, Kerbel RS, Jothy S, Dagnino L, Arbiser J, Klement G, Dumont DJ (2005) A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol 166:843-855 (Pubitemid 40315641)
344. Voskuil M, van Royen N, Hoefer IE, Seidler R, Guth BD, Bode C, Schaper W, Piek JJ, Buschmann IR (2003) Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol 284:H1422-1428 (Pubitemid 36348606)
345. Wada AM, Reese DE, Bader DM (2001) Bves: prototype of a new class of cell adhesion molecules expressed during coronary artery development. Development 128:2085-2093 (Pubitemid 32600469)
346. Waltenberger J (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49:554-560 (Pubitemid 32146418)
347. Wang HU, Chen ZF, Anderson DJ (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753 (Pubitemid 28257581)
348. WangHW, TrotterMW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C (2004)Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36:687-693 (Pubitemid 38886628)
349. Ward NL,Haninec AL,Van Slyke P, Sled JG, SturkC,Henkelman RM,Wanless IR,DumontDJ (2004) Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. Am J Pathol 165:889-899 (Pubitemid 39129296)
350. Weinstein M, Yang X, Deng C (2000) Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 11:49-58 (Pubitemid 30169725)
351. Willett CG, Boucher Y, di Tomaso E Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, KalvaSP,KozinSV,MinoM,CohenKS,ScaddenDT,HartfordAC, FischmanAJ,Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145-147 (Pubitemid 38524883)
352. Willett CG, Boucher Y, DudaDG, di Tomaso E,Munn LL, Tong RT, Kozin SV Petit L, Jain RK, ChungDC, SahaniDV,Kalva SP,Cohen KS, ScaddenDT, FischmanAJ,Clark JW,RyanDP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-KenudsonM, Lauwers GY (2005) Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 23:8136-8139 (Pubitemid 46657433)
353. Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553-563 (Pubitemid 40017699)
354. Wu CC, Lee CN, Chen TM, Shyu MK, Hsieh CY, Chen HY, Hsieh FJ (1994) Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 73:1251-1256.
355. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-168 (Pubitemid 36759650)
356. Xie W, McCahon P, Jakobsen K, Parish C (2004) Evaluation of the ability of digital infrared imaging to detect vascular changes in experimental animal tumours. Int J Cancer 108:790-794 (Pubitemid 38076413)
357. Xu Y, Yu Q (2001) Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 276:34990-34998
358. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328 (Pubitemid 36314418)
359. Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H (2004) Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53:1831-1840 (Pubitemid 38857042)
360. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT (2003) From scarless fetal wounds to keloids: molecular studies in wound healing.Wound Repair Regen 11:411-418 (Pubitemid 37467721)
361. YangR,ThomasGR,Bunting S,KoA,Ferrara N,KeytB,Ross J, JinH(1996)Effectsof vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 27:838-844 (Pubitemid 26000416)
362. Yano K, Brown LF, Detmar M (2001) Control of hair growth and follicle size by VEGFmediated angiogenesis. J Clin Invest 107:409-417 (Pubitemid 32167987)
363. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM (2001) Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 88:E2-E11
364. Yin G, Liu W, An P, Li P, Ding I, Planelles V, Schwarz EM, Min W (2002) Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol Ther 5:547-554 (Pubitemid 34546084)
365. Yousef GM, Diamandis EP (2002) Expanded human tissue kallikrein family-a novel panel of cancer biomarkers. Tumour Biol 23:185-192 (Pubitemid 44858310)
366. Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS (2002) Effect of p53 status on tumor response to antiangiogenic therapy. Science 295:1526-1528 (Pubitemid 34174008)
367. Zhong TP, Rosenberg M,Mohideen MA,Weinstein B, FishmanMC(2000) gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287:1820-1824 (Pubitemid 30143966)
368. Zhong TP, Childs S, Leu JP, Fishman MC (2001) Gridlock signalling pathway fashions the first embryonic artery. Nature 414:216-220 (Pubitemid 33051237)
369. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, SchaperW(2004) Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94:230-238 (Pubitemid 38197456)
370. Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28:202-208